Sam Amory - Spectral Med Pres Inc

All Insiders . USA . 
Stock . Spectral Med . Stakeholders . Insider . Sam Amory
EDTXF Stock  USD 0.34  0.01  2.86%   

Insider

Sam Amory is Pres Inc of Spectral Med
Phone416-626-3233
Webhttps://www.spectraldx.com

Spectral Med Management Efficiency

The company has return on total asset (ROA) of (0.7429) % which means that it has lost $0.7429 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.8381) %, meaning that it generated substantial loss on money invested by shareholders. Spectral Med's management efficiency ratios could be used to measure how well Spectral Med manages its routine affairs as well as how well it operates its assets and liabilities.
Spectral Med has accumulated 537 K in total debt with debt to equity ratio (D/E) of 0.26, which may suggest the company is not taking enough advantage from borrowing. Spectral Med has a current ratio of 2.33, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Spectral Med until it has trouble settling it off, either with new capital or with free cash flow. So, Spectral Med's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Spectral Med sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Spectral to invest in growth at high rates of return. When we think about Spectral Med's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Michael BellGuardant Health
56
Darya ChudovaGuardant Health
51
Corinna GorgesMainz Biomed BV
N/A
Guido BaechlerMainz Biomed BV
60
Rafael AguirreSacasaStandard Biotools
N/A
David KingStandard Biotools
N/A
Kara ThorntonNeuronetics
N/A
Claire SearsNeuronetics
N/A
Patricia CPAEnzo Biochem
48
William CaragolMainz Biomed BV
57
Peter ClemensEnzo Biochem
N/A
Rebecca FischerEnzo Biochem
52
Petra PloesserMainz Biomed BV
N/A
Nadia AltomareSera Prognostics
53
Vikram JogStandard Biotools
68
Xavier MSbioAffinity Technologies,
55
MBA MBASera Prognostics
70
Moritz EidensMainz Biomed BV
41
Bradley RadoffEnzo Biochem
47
Stephen LinthwaiteStandard Biotools
49
Kara CannonEnzo Biochem
56
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people. Spectral Med [EDTXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity-7.84
Return On Asset-0.74

Spectral Med Leadership Team

Elected by the shareholders, the Spectral Med's board of directors comprises two types of representatives: Spectral Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spectral. The board's role is to monitor Spectral Med's management team and ensure that shareholders' interests are well served. Spectral Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spectral Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sam Amory, Pres Inc
BSc RN, VP Devel
Blair McInnis, Chief Officer
Christopher Seto, CEO Director
John MD, Chief Officer

Spectral Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Spectral Med a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-7.84
Return On Asset-0.74
Operating Margin(6.38) %
Current Valuation65.99 M
Shares Outstanding278.22 M
Shares Owned By Insiders20.43 %
Shares Owned By Institutions13.18 %
Price To Earning(13.69) X
Price To Book51.73 X
Price To Sales42.75 X

Currently Active Assets on Macroaxis

FFord Motor
GMGeneral Motors
SSentinelOne
GOOGAlphabet Inc Class C
WDWalker Dunlop

Other Information on Investing in Spectral Pink Sheet

Spectral Med financial ratios help investors to determine whether Spectral Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY